Imaging Cancer in Pregnancy

Targeted CE per ARRT’s Discipline, Category, and Subcategory classification:
[Note: Discipline-specific Targeted CE credits may be less than the total Category A credits approved for this course.]

Computed Tomography: 0.75
Procedures: 0.75
Head, Spine, and Musculoskeletal: 0.25
Neck and Chest: 0.25
Abdomen and Pelvis: 0.25

Magnetic Resonance Imaging: 0.75
Procedures: 0.75
Neurological: 0.25
Body: 0.25
Musculoskeletal: 0.25

Nuclear Medicine Technology: 0.75
Procedures: 0.75
Endocrine and Oncology Procedures: 0.75

Registered Radiologist Assistant: 1.50
Safety: 0.25
Patient Safety, Radiation Protection, and Equipment Operation: 0.25
Procedures: 1.25
Abdominal Section: 1.25

Sonography: 0.75
Procedures: 0.75
Abdomen: 0.25
Gynecology: 0.25
Superficial Structures and Other Sonographic Procedures: 0.25

Radiation Therapy: 2.75
Patient Care: 1.25
Patient and Medical Record Management: 1.25
Safety: 0.25
Radiation Physics and Radiobiology: 0.25
Procedures: 1.25
Treatment Sites and Tumors: 1.25

Outline

1. Introduction

Objectives

Upon completion of this course, students will:

1. define pregnancy associated cancer
2. list the factors that aid in the detection of pregnancy-associated cancer
3. state the basis for treatment selection for patients with pregnancy-associated cancer
4. state the most common cause of death in women of childbearing age
5. recall the incidence of pregnancy-related cancers
6. list the most common pregnancy-associated cancers
7. list the typical physiologic symptoms of pregnancy
8. state the percent of pregnancy-related cancers that are diagnosed in the post-partum period
9. choose the non-ionizing modalities that can be utilized for the detection of cancer in pregnant patients
10. list the types of computed tomography exams that have negligible fetal exposure
11. state the two types of radiation exposure
12. provide the most vulnerable period of gestation for intellectual disability as it pertains to radiation exposure
13. state the percent of exposed fetuses that will not develop a childhood cancer or leukemia
14. explain counseling and informed consent procedures for imaging during pregnancy
15. choose the most common imaging modality utilized for routine prenatal care
16. list the MRI systems strengths that can be used for imaging in pregnancy
17. state the American Academy of Pediatrics recommendation for fetal sound exposure
18. provide the pregnancy drug category for Gadolinium
19. choose what type of contrast material remains in the maternal gastrointestinal tract and is considered safe for administration during pregnancy
20. explain how radiopharmaceuticals affect breast feeding
21. list the key points of discussion with family members of pregnancy associated cancer patients
22. know the frequency of pregnancy associated breast cancer
23. state the reported incidence of BRCA-1 mutations with pregnancy-associated breast cancer
24. list how patients with pregnancy-associated breast cancer present clinically
25. state the percentage of biopsied palpable masses in pregnant and lactating patients that are benign
26. list how treatment options for pregnancy-associated breast cancer are determined
27. state the percent of hematologic malignancies associated with pregnancy-associated cancers
28. state the most common hematologic malignancy in pregnant patients
29. recall the number of cervical cancer cases in pregnant patients
30. list the number of malignant ovarian masses per 100,000 patients
31. choose the imaging modality of choice for sonographically indeterminate adnexal masses
32. state the percentage of pregnancy-associated gastrointestinal cancers
33. choose the most common site of colorectal cancer during pregnancy
34. select the major risk factor for development of pancreatic adenocarcinoma in pregnancy
35. describe thyroid cancers diagnosed in pregnancy